Analysis at 5 dpi showed modest but significant decreases in viral RNA copy and cytokine expression (Supplementary Fig. 14), which suggests a therapeutic potential of engineered ACE2 against human COVID-19. This evidence concerns the gene ACE2 and COVID-19.